Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • Should speculations about immune-mediated adverse effects of Lyme disease vaccine deter us from giving it?
    You have access
    Should speculations about immune-mediated adverse effects of Lyme disease vaccine deter us from giving it?
    Leonard Sigal, MD
    Cleveland Clinic Journal of Medicine December 2000, 67 (12) 873-874;

    The vaccine is safe, but should not replace simple common-sense precautions in tick-infested areas.

  • You have access
    Pharmacologic aids to smoking cessation
    Trudy D. Helge, PsyD and Garland Y. DeNelsky, PhD
    Cleveland Clinic Journal of Medicine November 2000, 67 (11) 818-824;

    Quitting smoking is notoriously hard. Drugs can improve the odds of quitting, but the best approach is multifactorial.

  • You have access
    A 65-year-old factory worke with dyspnea on exertion and a normal chest x-ray
    Walid Saber, MD and Raed A. Dweik, MD
    Cleveland Clinic Journal of Medicine November 2000, 67 (11) 791-800;

    What is the cause of this patient’s symptoms? A self-test on a clinical case.

  • You have access
    In diabetes, treat hidden heart disease
    Willa A. Hsueh, MD
    Cleveland Clinic Journal of Medicine November 2000, 67 (11) 807-813;

    Both diabetic and prediabetic patients have abnormal vascular reactivity and should be considered to have occult cardiovascular disease.

  • You have access
    A 70-year-old farmer with a skin lesion
    Elizabeth F. Callahan, MD and Kenneth J. Tomecki, MD
    Cleveland Clinic Journal of Medicine November 2000, 67 (11) 814;

    Questions and answers on the visible signs of diseases.

  • You have access
    Using troponin T to diagnose acute coronary syndromes
    Ellen McErlean, MSN, RN, CCRN, Frederick Van Lente, MD and Steven E. Nissen, MD
    Cleveland Clinic Journal of Medicine November 2000, 67 (11) 843-849;

    Troponin T and creatine kinase MB have complementary roles. Includes a diagnostic algorithm.

  • Preventing skin cancer
    You have access
    Preventing skin cancer
    Cleveland Clinic Journal of Medicine November 2000, 67 (11) 817;
  • You have access
    Heart failure is a fever: The cytokine connection
    James B. Young, MD
    Cleveland Clinic Journal of Medicine November 2000, 67 (11) 801-803;

    The discovery that inflammation contributes to heart failure may lead to new therapies for this disease.

  • You have access
    Factor V Leiden and Prothrombin G20210A
    Steven R. Deitcher, MD, Enrico Caiola, MD and Amir Jaffer, MD
    Cleveland Clinic Journal of Medicine November 2000, 67 (11) 825-836;

    Genetic testing is useful only if the knowledge gained will affect the course of treatment.

  • You have access
    Treatment of ovarian cancers not of epithelial origin
    Cleveland Clinic Journal of Medicine November 2000, 67 (11) 839-842;

    Some ovarian cancers carry a prognosis quite different from that of epithelial ovarian cancer, and call for totally different treatment.

Pages

  • Previous
  • Next
  • 1
  • …
  • 411
  • 412
  • 413
  • 414
  • 415
  • 416
  • 417
  • 418
  • 419
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire